Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

  title={Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination},
  author={Andrew S Ishizuka and Kirsten E. Lyke and Adam Dezure and Andrea Berry and Thomas L. Richie and Floreliz H Mendoza and Mary E. Enama and Ingelise J. Gordon and Lee-Jah Chang and Uzma N Sarwar and Kathryn L. Zephir and Lasonji Holman and Eric R. James and Peter F. Billingsley and A. Viran Gunasekera and Sumana Chakravarty and Anita Manoj and Minglin Li and Adam J. Ruben and Tao Li and Abraham G. Eappen and Richard E. Stafford and C NatashaK and Tooba Murshedkar and Hope DeCederfelt and Sarah H. Plummer and Cynthia S. Hendel and Laura Novik and Pamela J M Costner and Jamie G Saunders and Matthew B Laurens and Christopher V. Plowe and Barbara Flynn and William R Whalen and John Paul Todd and Jay Noor and Srinivas Ponnam Rao and Kailan Sierra-Davidson and Geoffrey M Lynn and Judith E. Epstein and Margaret A Kemp and Gary A. Fahle and Sebastian A Mikolajczak and Matthew E. Fishbaugher and Brandon K Sack and Stefan H. I. Kappe and Silas A. Davidson and Lindsey S Garver and Niklas K Bj{\"o}rkstr{\"o}m and Martha C. Nason and Barney S. Graham and Mario Roederer and Betty Kim Lee Sim and Stephen L Hoffman and Julie E. Ledgerwood and Robert A. Seder},
  journal={Nature Medicine},
An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown. We assessed how vaccine dosage, regimen, and route of administration affected durable protection in malaria-naive adults. After four intravenous immunizations with 2.7 × 10(5) PfSPZ, 6/11 (55%) vaccinated subjects remained without parasitemia following CHMI 21 weeks after… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
0 Extracted Citations
50 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 50 references

final results of a phase 3, individually randomized, controlled trial

  • RTS, S Clinical Trials Partnership. Efficacy, safety of RTS, SAS01 malaria vaccine with or without a booster dose in infants, children in Africa
  • Lancet 386, 31–45
  • 2015

In vivo imaging of CD 8 + T cell – mediated elimination of malaria liver stages

  • I. A. Cockburn
  • Proc . Natl . Acad . Sci . USA
  • 2013

In vivo imaging of CD8+ T cell–mediated elimination of malaria liver

  • Cockburn, I.A
  • stages. Proc. Natl. Acad. Sci. USA 110,
  • 2013

Similar Papers

Loading similar papers…